252 related articles for article (PubMed ID: 26699870)
1. Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.
Sharma A; Hoover DR; Shi Q; Gustafson D; Plankey MW; Hershow RC; Tien PC; Golub ET; Anastos K
PLoS One; 2015; 10(12):e0143740. PubMed ID: 26699870
[TBL] [Abstract][Full Text] [Related]
2. Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study.
Sharma A; Bynum SA; Schneider MF; Cox C; Tien PC; Hershow RC; Gustafson D; Plankey MW
J AIDS Clin Res; 2014; 5():. PubMed ID: 25580365
[TBL] [Abstract][Full Text] [Related]
3. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
[TBL] [Abstract][Full Text] [Related]
4. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.
Murphy K; Hoover DR; Shi Q; Cohen M; Gandhi M; Golub ET; Gustafson DR; Pearce CL; Young M; Anastos K
AIDS; 2013 Sep; 27(15):2413-23. PubMed ID: 24037210
[TBL] [Abstract][Full Text] [Related]
5. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
[TBL] [Abstract][Full Text] [Related]
6. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
Estrella MM; Parekh RS; Abraham A; Astor BC; Szczech LA; Anastos K; Dehovitz JA; Merenstein DJ; Pearce CL; Tien PC; Cohen MH; Gange SJ
J Acquir Immune Defic Syndr; 2010 Oct; 55(2):217-20. PubMed ID: 20581688
[TBL] [Abstract][Full Text] [Related]
7. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Berhane K; Karim R; Cohen MH; Masri-Lavine L; Young M; Anastos K; Augenbraun M; Watts DH; Levine AM
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1245-52. PubMed ID: 15385731
[TBL] [Abstract][Full Text] [Related]
8. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
Smit C; Geskus R; Walker S; Sabin C; Coutinho R; Porter K; Prins M;
AIDS; 2006 Mar; 20(5):741-9. PubMed ID: 16514305
[TBL] [Abstract][Full Text] [Related]
9. An optimal BMI range associated with a lower risk of mortality among HIV-infected adults initiating antiretroviral therapy in Guangxi, China.
Jiang J; Qin X; Liu H; Meng S; Abdullah AS; Huang J; Qin C; Liu Y; Huang Y; Qin F; Huang J; Zang N; Liang B; Ning C; Liao Y; Liang H; Wu F; Ye L
Sci Rep; 2019 May; 9(1):7816. PubMed ID: 31127157
[TBL] [Abstract][Full Text] [Related]
10. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
[TBL] [Abstract][Full Text] [Related]
11. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
[TBL] [Abstract][Full Text] [Related]
12. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.
Gingo MR; Balasubramani GK; Kingsley L; Rinaldo CR; Alden CB; Detels R; Greenblatt RM; Hessol NA; Holman S; Huang L; Kleerup EC; Phair J; Sutton SH; Seaberg EC; Margolick JB; Wisniewski SR; Morris A
PLoS One; 2013; 8(3):e58812. PubMed ID: 23554932
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and risk of tuberculosis and death.
Hanrahan CF; Golub JE; Mohapi L; Tshabangu N; Modisenyane T; Chaisson RE; Gray GE; McIntyre JA; Martinson NA
AIDS; 2010 Jun; 24(10):1501-8. PubMed ID: 20505496
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
Gutierrez F; Padilla S; Masiá M; Iribarren JA; Moreno S; Viciana P; Muñoz L; Gómez Sirvent JL; Vidal F; López-Aldeguer J; Blanco JR; Leal M; Rodríguez-Arenas MA; Perez Hoyos S;
PLoS One; 2006 Dec; 1(1):e89. PubMed ID: 17183720
[TBL] [Abstract][Full Text] [Related]
15. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.
Wada N; Jacobson LP; Cohen M; French A; Phair J; Muñoz A
Am J Epidemiol; 2013 Jan; 177(2):116-25. PubMed ID: 23287403
[TBL] [Abstract][Full Text] [Related]
16. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
Wood E; Hogg RS; Lima VD; Kerr T; Yip B; Marshall BD; Montaner JS
JAMA; 2008 Aug; 300(5):550-4. PubMed ID: 18677027
[TBL] [Abstract][Full Text] [Related]
17. Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.
Anastos K; Shi Q; French AL; Levine A; Greenblatt RM; Williams C; DeHovitz J; Delapenha R; Hoover DR
J Acquir Immune Defic Syndr; 2004 Apr; 35(4):383-92. PubMed ID: 15097155
[TBL] [Abstract][Full Text] [Related]
18. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.
Kouanda S; Meda IB; Nikiema L; Tiendrebeogo S; Doulougou B; Kaboré I; Sanou MJ; Greenwell F; Soudré R; Sondo B
AIDS Care; 2012; 24(4):478-90. PubMed ID: 22148973
[TBL] [Abstract][Full Text] [Related]
19. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use.
Kapadia F; Cook JA; Cohen MH; Sohler N; Kovacs A; Greenblatt RM; Choudhary I; Vlahov D
Addiction; 2005 Jul; 100(7):990-1002. PubMed ID: 15955015
[TBL] [Abstract][Full Text] [Related]
20. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study.
Feldman JG; Minkoff H; Schneider MF; Gange SJ; Cohen M; Watts DH; Gandhi M; Mocharnuk RS; Anastos K
Am J Public Health; 2006 Jun; 96(6):1060-5. PubMed ID: 16670229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
